- Home
- LOVE vs YMAB Comparison
LOVE vs YMAB Comparison
Compare LOVE & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOVE
- YMAB
- Stock Information
- Founded
- LOVE 1998
- YMAB 2015
- Country
- LOVE United States
- YMAB United States
- Employees
- LOVE N/A
- YMAB N/A
- Industry
- LOVE Other Specialty Stores
- YMAB Biotechnology: Pharmaceutical Preparations
- Sector
- LOVE Consumer Discretionary
- YMAB Health Care
- Exchange
- LOVE Nasdaq
- YMAB Nasdaq
- Market Cap
- LOVE N/A
- YMAB 270.5M
- IPO Year
- LOVE 2018
- YMAB 2018
- Fundamental
- Price
- LOVE $18.65
- YMAB $4.81
- Analyst Decision
- LOVE Strong Buy
- YMAB Buy
- Analyst Count
- LOVE 5
- YMAB 11
- Target Price
- LOVE $38.40
- YMAB $18.73
- AVG Volume (30 Days)
- LOVE 496.0K
- YMAB 349.7K
- Earning Date
- LOVE 04-10-2025
- YMAB 03-04-2025
- Dividend Yield
- LOVE N/A
- YMAB N/A
- EPS Growth
- LOVE N/A
- YMAB N/A
- EPS
- LOVE 0.43
- YMAB N/A
- Revenue
- LOVE $689,645,000.00
- YMAB $87,685,000.00
- Revenue This Year
- LOVE N/A
- YMAB $20.07
- Revenue Next Year
- LOVE $7.46
- YMAB $8.76
- P/E Ratio
- LOVE $43.40
- YMAB N/A
- Revenue Growth
- LOVE 0.20
- YMAB 3.38
- 52 Week Low
- LOVE $15.22
- YMAB $4.25
- 52 Week High
- LOVE $39.49
- YMAB $17.78
- Technical
- Relative Strength Index (RSI)
- LOVE 47.65
- YMAB 40.82
- Support Level
- LOVE $16.95
- YMAB $4.65
- Resistance Level
- LOVE $18.88
- YMAB $5.32
- Average True Range (ATR)
- LOVE 0.82
- YMAB 0.30
- MACD
- LOVE 0.50
- YMAB 0.07
- Stochastic Oscillator
- LOVE 93.72
- YMAB 41.38
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.